Human umbilical cord mesenchymal stem cells (Sclnow Biotechnology)

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameHuman umbilical cord mesenchymal stem cells (Sclnow Biotechnology)
Drug Alias NamehucMSCs (Sclnow Biotechnology)脐带间充质干细胞疗法Umbilical cord mesenchymal stem cell therapy (Sclnow Biotechnology)19#iSCLife®-CSDhUC Mesenchymal Stem Cells (Sclnow Biotechnology) +[9] 
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsUterine DiseasesInfertility, FemalePrimary Ovarian Insufficiency +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSclnow Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSclnow Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsUterine DiseasesInfertility, FemaleInfertility +[5] 
Inactive IndicationsPrimary Ovarian InsufficiencyIntervertebral Disc Degeneration

Other Information

ATC CodeN/A
Related LinksN/A